|
ZNTL Zentalis Pharmaceuticals Inc 1725160 |
| Balance Sheet |
|
Current Assets
|
400,270,000 |
|
Assets
|
450,661,000 |
|
Current Liabilities
|
54,877,000 |
|
Liabilities
|
96,330,000 |
|
Equity
|
354,331,000 |
|
Shares Out
|
71,108,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-131,158,000 |
|
Investing Cash Flow
|
144,278,000 |
| Market Analysis |
Market Cap
|
302,516,418 |
|
Price
|
1.80 |
|
BVPS
|
4.98 |
|
PB
|
0.36 |
|
EPS
|
-2.75 |
|
PS
|
2.05 |
|
FCF
|
13,120,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ZNTL documents filed with the SEC.
ZNTL Filings
Clear
